The results by Hai-Hui “Howard” Xue, Ph.D., and colleagues are published in the latest edition of Science Immunology—and could have implications in cancer immunotherapy and vaccine developments for years to come.

Establishing cellular immunity depends on the thymus, a lymph gland located in front of the heart. This gland produces and exports T cells, a workhorse white blood cell, out to the rest of the body, using the building blocks of stem cells from the bone marrow. But it has remained a riddle how T cell fate is initiated.

The new paper shows that two protein “transcription factors” called Tcf1 and Lef1 are critical modulators that direct bone marrow stem cells to the T cell path in the thymus.